Cargando…
SARS-CoV-2 vaccine antibody response and breakthrough infection in dialysis
BACKGROUND: Patients receiving dialysis are a sentinel population for groups at high risk for death and disability from COVID-19. Understanding correlates of protection post-vaccination can inform immunization and mitigation strategies. METHODS: Monthly since January 2021, we tested plasma from 4791...
Autores principales: | Anand, Shuchi, Montez-Rath, Maria E., Han, Jialin, Garcia, Pablo, Cadden, LinaCel, Hunsader, Patti, Morgan, Curt, Kerschmann, Russell, Beyer, Paul, Dittrich, Mary, Block, Geoffrey A, Chertow, Glenn M, Parsonnet, Julie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528091/ https://www.ncbi.nlm.nih.gov/pubmed/34671782 http://dx.doi.org/10.1101/2021.10.12.21264860 |
Ejemplares similares
-
SARS-CoV-2 infection during the Omicron surge among patients receiving dialysis: the role of circulating receptor-binding domain antibodies and vaccine doses
por: Montez-Rath, Maria E., et al.
Publicado: (2022) -
Antibody Response to COVID-19 vaccination in Patients Receiving Dialysis
por: Anand, Shuchi, et al.
Publicado: (2021) -
Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic
por: Anand, Shuchi, et al.
Publicado: (2021) -
Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study
por: Anand, Shuchi, et al.
Publicado: (2020) -
Laboratory correlates of SARS-CoV-2 seropositivity in a nationwide sample of patients on dialysis in the U.S.
por: Anand, Shuchi, et al.
Publicado: (2021)